MICHELE REISINGER: Open Payments
NPI 1821078353 · ONAGA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 16 payments from 9 companies in 2025. Trend: 2023 $164 · 2024 $105 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Melinta Therapeutics, LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| PFIZER INC. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Lilly USA, LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $15 |
| Electromed, Inc. | 1 | $14 |
Products named: CAPLYTA, Kimyrsa, EOHILIA, PREVNAR 20, LEQVIO, MOUNJARO, Dexcom G6 Transmitter, Veozah.
Industry payments across KS — which companies pay providers there.
